Invivyd IVVD
NASDAQ IVVD
$0.87 +0.01 (+1.75%)
As of: Sep 30, 2026 · 3:59 PM EDT

Invivyd (IVVD) EBIT Margin (2024 - 2026)

Updated

Invivyd's EBIT Margin came in at -320.76% for Q2 2026, down 192.98 percentage points from -127.78% a year earlier.

Analysis

Invivyd (IVVD) EBIT Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Invivyd reported EBIT Margin of -149.73%, up 95.94 percentage points year-over-year; for FY2025, it came in at -103.99%, up 592.81 percentage points from FY2024.

  • Going back by year, EBIT Margin was -696.80% in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q3 2024.
  • Year-over-year, EBIT Margin increased in three of the last four quarters, with an average year-over-year change of +626.67 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Invivyd 250.54 Mn -256.10 Mn 13.01 Mn -320.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -320.76%
Dec 31, 2025 -72.96%
Sep 30, 2025 -83.96%
Jun 30, 2025 -127.78%
Mar 31, 2025 -149.70%
Dec 31, 2024 -139.14%
Sep 30, 2024 -670.01%
Jun 30, 2024 -2,175.22%
API Access

Invivyd EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY